Does cytochrome P450 1A1 MspI polymorphism increase acute lymphoblastic leukemia risk? Evidence from 2013 cases and 2903 controls

Gene

Volumn 510, Issue 1, 2012, Pages 14-21

  Zhuo, Wenlei ^a   Zhang, Liang ^a   Qiu, Zhiqun ^a   Zhu, Bo ^a   Chen, Zhengtang ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Acute lymphoblastic leukemia; CYP1A1 MspI; Malignancy; Meta analysis; Polymorphism; Susceptibility

Indexed keywords

CYTOCHROME P450 1A1;

ACUTE LYMPHOBLASTIC LEUKEMIA; AGE; ARTICLE; ASIAN; CANCER RISK; CAUCASIAN; ETHNICITY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

ADOLESCENT; ADULT; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; BINDING SITES; CHILD; CHILD, PRESCHOOL; CYTOCHROME P-450 CYP1A1; DEOXYRIBONUCLEASE HPAII; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INFANT; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RISK ASSESSMENT; RISK FACTORS; YOUNG ADULT;

EID: 84866948272     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2012.08.042     Document Type: Article

References (54)

1. Aydin-Sayitoglu M., Hatirnaz O., Erensoy N., Ozbek U. Role of CYP2D6, CYP1A1, CYP2E1, GSTT1, and GSTM1 genes in the susceptibility to acute leukemias. Am. J. Hematol. 2006, 81:162-170.
2. Balta G., et al. Characterization of MTHFR, GSTM1, GSTT1, GSTP1, and CYP1A1 genotypes in childhood acute leukemia. Am. J. Hematol. 2003, 73:154-160.
3. Bhatia S., Sather H.N., Heerema N.A., Trigg M.E., Gaynon P.S., Robison L.L. Racial and ethnic differences in survival of children with acute lymphoblastic leukemia. Blood 2002, 100:1957-1964.
4. Boffetta P. Biomarkers in cancer epidemiology: an integrative approach. Carcinogenesis 2010, 31:121-126.
5. Bolufer P., et al. The potential effect of gender in combination with common genetic polymorphisms of drug-metabolizing enzymes on the risk of developing acute leukemia. Haematologica 2007, 92:308-314.
6. Bonaventure A., et al. Maternal smoking during pregnancy, genetic polymorphisms of metabolic enzymes, and childhood acute leukemia: the ESCALE study (SFCE). Cancer Causes Control 2012, 23:329-345.
7. Canalle R., Burim R.V., Tone L.G., Takahashi C.S. Genetic polymorphisms and susceptibility to childhood acute lymphoblastic leukemia. Environ. Mol. Mutagen. 2004, 43:100-109.
8. Castro-Jimenez M.A., Orozco-Vargas L.C. Parental exposure to carcinogens and risk for childhood acute lymphoblastic leukemia, Colombia, 2000-2005. Prev. Chronic Dis. 2011, 8:A106.
9. Chen H.C., et al. Genetic polymorphisms of metabolic enzymes CYP1A1, CYP2D6, GSTM1 and GSTT1 and leukemia susceptibility. Eur. J. Cancer Prev. 2008, 17:251-258.
10. Clavel J., et al. Childhood leukaemia, polymorphisms of metabolism enzyme genes, and interactions with maternal tobacco, coffee and alcohol consumption during pregnancy. Eur. J. Cancer Prev. 2005, 14:531-540.
11. Egger M., Davey Smith G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629-634.
12. Gallegos-Arreola M.P., Gonzalez-Garcia J.R., Figuera L.E., Puebla-Perez A.M., Delgado-Lamas J.L., Zuniga-Gonzalez G.M. Distribution of CYP1A1*2A polymorphism in adult patients with acute lymphoblastic leukemia in a Mexican population. Blood Cells Mol. Dis. 2008, 41:91-94.
13. Gao J., Huang Y., Liang J., Fang X. Relationship between genetic polymorphisms of CYP1A1 and ALL. Chin. J. Birth Health Hered. 2003, 11:21-24.
14. Guengerich F.P., Shimada T. Activation of procarcinogens by human cytochrome P450 enzymes. Mutat. Res. 1998, 400:201-213.
15. Guo R., Guo X. Quantitative assessment of the associations between CYP1A1 polymorphisms and gastric cancer risk. Tumour Biol. 2012, 33:1125-1134.
16. Higgins J.P., Thompson S.G., Deeks J.J., Altman D.G. Measuring inconsistency in meta-analyses. BMJ 2003, 327:557-560.
17. Ilhan G., Karakus S., Andic N. Risk factors and primary prevention of acute leukemia. Asian Pac. J. Cancer Prev. 2006, 7:515-517.
18. Infante-Rivard C., Labuda D., Krajinovic M., Sinnett D. Risk of childhood leukemia associated with exposure to pesticides and with gene polymorphisms. Epidemiology 1999, 10:481-487.
19. Infante-Rivard C., Krajinovic M., Labuda D., Sinnett D. Parental smoking, CYP1A1 genetic polymorphisms and childhood leukemia (Quebec, Canada). Cancer Causes Control 2000, 11:547-553.
20. Joseph T., Kusumakumary P., Chacko P., Abraham A., Radhakrishna Pillai M. Genetic polymorphism of CYP1A1, CYP2D6, GSTM1 and GSTT1 and susceptibility to acute lymphoblastic leukaemia in Indian children. Pediatr. Blood Cancer 2004, 43:560-567.
21. Klaunig J.E., Kamendulis L.M., Hocevar B.A. Oxidative stress and oxidative damage in carcinogenesis. Toxicol. Pathol. 2010, 38:96-109.
22. Krajinovic M., Labuda D., Richer C., Karimi S., Sinnett D. Susceptibility to childhood acute lymphoblastic leukemia: influence of CYP1A1, CYP2D6, GSTM1, and GSTT1 genetic polymorphisms. Blood 1999, 93:1496-1501.
23. Krajinovic M., Richer C., Sinnett H., Labuda D., Sinnett D. Genetic polymorphisms of N-acetyltransferases 1 and 2 and gene-gene interaction in the susceptibility to childhood acute lymphoblastic leukemia. Cancer Epidemiol. Biomarkers Prev. 2000, 9:557-562.
24. Krajinovic M., et al. Polymorphisms in genes encoding drugs and xenobiotic metabolizing enzymes, DNA repair enzymes, and response to treatment of childhood acute lymphoblastic leukemia. Clin. Cancer Res. 2002, 8:802-810.
25. Lee K.M., et al. Paternal smoking, genetic polymorphisms in CYP1A1 and childhood leukemia risk. Leuk. Res. 2009, 33:250-258.
26. Liu Q.X., Chen H.C., Liu X.F., Cao Y.F., Zhang J., Liu J. Study on the relationship between polymorphisms of Cyp1A1, GSTM1, GSTT1 genes and the susceptibility to acute leukemia in the general population of Hunan province. Zhonghua Liu Xing Bing Xue Za Zhi 2005, 26:975-979.
27. MacArthur A.C., McBride M.L., Spinelli J.J., Tamaro S., Gallagher R.P., Theriault G. Risk of childhood leukemia associated with parental smoking and alcohol consumption prior to conception and during pregnancy: the cross-Canada childhood leukemia study. Cancer Causes Control 2008, 19:283-295.
28. Manuguerra M., et al. Multi-factor dimensionality reduction applied to a large prospective investigation on gene-gene and gene-environment interactions. Carcinogenesis 2007, 28:414-422.
29. Mathonnet G., Krajinovic M., Labuda D., Sinnett D. Role of DNA mismatch repair genetic polymorphisms in the risk of childhood acute lymphoblastic leukaemia. Br. J. Haematol. 2003, 123:45-48.
30. Mullighan C.G. Genetic variation and the risk of acute lymphoblastic leukemia. Leuk. Res. 2010, 34:1269-1270.
31. Munafo M.R., Clark T.G., Flint J. Assessing publication bias in genetic association studies: evidence from a recent meta-analysis. Psychiatry Res. 2004, 129:39-44.
32. Plasschaert S.L., Kamps W.A., Vellenga E., de Vries E.G., de Bont E.S. Prognosis in childhood and adult acute lymphoblastic leukaemia: a question of maturation?. Cancer Treat. Rev. 2004, 30:37-51.
33. Sergentanis T.N., Economopoulos K.P. Four polymorphisms in cytochrome P450 1A1 (CYP1A1) gene and breast cancer risk: a meta-analysis. Breast Cancer Res. Treat. 2010, 122:459-469.
34. Sergentanis T.N., Economopoulos K.P., Choussein S., Vlahos N.F. Cytochrome P450 1A1 (CYP1A1) gene polymorphisms and cervical cancer risk: a meta-analysis. Mol. Biol. Rep. 2012, 39:6647-6654.
35. Shaik A.P., Jamil K., Das P. CYP1A1 polymorphisms and risk of prostate cancer: a meta-analysis. Urol. J. 2009, 6:78-86.
36. Shu X.O., et al. Parental exposure to medications and hydrocarbons and ras mutations in children with acute lymphoblastic leukemia: a report from the Children's Oncology Group. Cancer Epidemiol. Biomarkers Prev. 2004, 13:1230-1235.
37. Sinnett D., Krajinovic M., Labuda D. Genetic susceptibility to childhood acute lymphoblastic leukemia. Leuk. Lymphoma 2000, 38:447-462.
38. Styczynski J., Pieters R., Huismans D.R., Schuurhuis G.J., Wysocki M., Veerman A.J. In vitro drug resistance profiles of adult versus childhood acute lymphoblastic leukaemia. Br. J. Haematol. 2000, 110:813-818.
39. Suneetha K.J., Nancy K.N., Rajalekshmy K.R., Rama R., Sagar T.G., Rajkumar T. Role of glutathione-s-transferase and CYP1A1*2A polymorphisms in the therapy outcome of south Indian acute lymphoblastic leukemia patients. Indian J. Med. Paediatr. Oncol. 2011, 32:25-29.
40. Swinney R.M., et al. Polymorphisms in CYP1A1 and ethnic-specific susceptibility to acute lymphoblastic leukemia in children. Cancer Epidemiol. Biomarkers Prev. 2011, 20:1537-1542.
41. Tobias A. Assessing the influence of a single study in the meta-analysis estimate. Stata Tech. Bull. 1999, 8:15-17.
42. Vijayakrishnan J., Houlston R.S. Candidate gene association studies and risk of childhood acute lymphoblastic leukemia: a systematic review and meta-analysis. Haematologica 2010, 95:1405-1414.
43. Wang L., Yin F., Xu X., Hu X., Zhao D. X-Ray Repair Cross-Complementing Group 1 (XRCC1) genetic polymorphisms and risk of childhood acute lymphoblastic leukemia: a meta-analysis. PLoS One 2012, 7:e34897.
44. Yamaguti G.G., Lourenco G.J., Silveira V.S., Tone L.G., Lopes L.F., Lima C.S. Increased risk for acute lymphoblastic leukemia in children with cytochrome P450A1 (CYP1A1)- and NAD(P)H:quinone oxidoreductase 1 (NQO1)-inherited gene variants. Acta Haematol. 2010, 124:182-184.
45. Yan J., et al. A meta-analysis of MTHFR C677T and A1298C polymorphisms and risk of acute lymphoblastic leukemia in children. Pediatr. Blood Cancer 2012, 58:513-518.
46. Yang Y., et al. A case-only study of interactions between metabolic enzyme polymorphisms and industrial pollution in childhood acute leukemia. Environ. Toxicol. Pharmacol. 2009, 28:161-166.
47. Ye Z., Song H. Glutathione s-transferase polymorphisms (GSTM1, GSTP1 and GSTT1) and the risk of acute leukaemia: a systematic review and meta-analysis. Eur. J. Cancer 2005, 41:980-989.
48. Yu K., et al. Methionine synthase A2756G polymorphism and cancer risk: a meta-analysis. Eur. J. Hum. Genet. 2010, 18:370-378.
49. Zhan P., Wang Q., Qian Q., Wei S.Z., Yu L.K. CYP1A1 MspI and exon7 gene polymorphisms and lung cancer risk: an updated meta-analysis and review. J. Exp. Clin. Cancer Res. 2011, 30:99.
50. Zhang Y.D., Tan L.N., Zhang X.L., Wei H.Y., Xiong H., Hu Q. Meta-analysis of cytochrome P4501A1 MspI gene polymorphism and childhood acute leukemia. Biomed. Environ. Sci. 2011, 24:683-687.
51. Zheng Y., Wang J.J., Sun L., Li H.L. Association between CYP1A1 polymorphism and colorectal cancer risk: a meta-analysis. Mol. Biol. Rep. 2012, 39:3533-3540.
52. Zhou S.F., Liu J.P., Chowbay B. Polymorphism of human cytochrome P450 enzymes and its clinical impact. Drug Metab. Rev. 2009, 41:89-295.
53. Zhuo W.L., Wang Y., Zhuo X.L., Zhu B., Zhu Y., Chen Z.T. Polymorphisms of CYP1A1 and GSTM1 and laryngeal cancer risk: evidence-based meta-analyses. J. Cancer Res. Clin. Oncol. 2009, 135:1081-1090.
54. Zhuo W.L., et al. Association studies of CYP1A1 and GSTM1 polymorphisms with esophageal cancer risk: evidence-based meta-analyses. Arch. Med. Res. 2009, 40:169-179.